You can access any of the podium or poster presentations’ abstracts by searching for it below.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (10) |
Back to Search
Pharmacokinetics and efficacy of Decitabine in restoration of RIP3 for potential therapeutic target for cancer
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-A-082-Monday
- By: KIM, You-Sun (Ajou University School of Medicine, Biochemistry, Suwon, Korea, Republic Of)
- Co-author(s): You-Sun Kim: Biochemistry, Ajou University School of Medicine, Suwon, Korea, Republic Of
- Abstract:
Backgrounds
Receptor-interacting protein kinase-3 (RIP3, or RIPK3) is an essential part of the cellular machinery that executes the programmed, or “regulated”, necrotic cell death pathway. Recently, we found that RIP3 expression is often silenced in cancer cells due to genomic methylation near its transcriptional start site and RIP3 expression is.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 2 July 2026